N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide

C24H30N4O5 — CID 93131858

IUPACN-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide
SMILESO=C(C1CCC1)N(CCN1CCOCC1)CC(=O)N1N=C(c2ccco2)C[C@H]1c1ccco1
InChIInChI=1S/C24H30N4O5/c29-23(17-27(24(30)18-4-1-5-18)9-8-26-10-14-31-15-11-26)28-20(22-7-3-13-33-22)16-19(25-28)21-6-2-12-32-21/h2-3,6-7,12-13,18,20H,1,4-5,8-11,14-17H2/t20-/m0/s1
InChIKeyMKORPHOHQVELLQ-FQEVSTJZSA-N
MW454.53 g/mol
LogP2.51
Rot. Bonds8

About N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide

N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide (PubChem CID 93131858) has the molecular formula C24H30N4O5 and a molecular weight of 454.53 g/mol. Its IUPAC name is N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide.

Molecular Properties

Compound NameN-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide
PubChem CID93131858
Molecular FormulaC24H30N4O5
Molecular Weight454.53 g/mol
Exact Mass454.22
IUPAC NameN-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide
SMILESO=C(C1CCC1)N(CCN1CCOCC1)CC(=O)N1N=C(c2ccco2)C[C@H]1c1ccco1
InChIInChI=1S/C24H30N4O5/c29-23(17-27(24(30)18-4-1-5-18)9-8-26-10-14-31-15-11-26)28-20(22-7-3-13-33-22)16-19(25-28)21-6-2-12-32-21/h2-3,6-7,12-13,18,20H,1,4-5,8-11,14-17H2/t20-/m0/s1
InChIKeyMKORPHOHQVELLQ-FQEVSTJZSA-N
XLogP2.51
TPSA91.73 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500454.53
LogP ≤ 52.51
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide?
The IUPAC name of N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide (CID 93131858) is N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide.
What is the SMILES notation for N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide?
The canonical SMILES for N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide is O=C(C1CCC1)N(CCN1CCOCC1)CC(=O)N1N=C(c2ccco2)C[C@H]1c1ccco1.
What is the InChIKey of N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide?
The InChIKey is MKORPHOHQVELLQ-FQEVSTJZSA-N. The full InChI is InChI=1S/C24H30N4O5/c29-23(17-27(24(30)18-4-1-5-18)9-8-26-10-14-31-15-11-26)28-20(22-7-3-13-33-22)16-19(25-28)21-6-2-12-32-21/h2-3,6-7,12-13,18,20H,1,4-5,8-11,14-17H2/t20-/m0/s1.
What are the key properties of N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide?
N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide has a molecular weight of 454.53 g/mol, XLogP of 2.51, 8 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(3S)-3,5-bis(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]-N-(2-morpholin-4-ylethyl)cyclobutanecarboxamide is sourced from PubChem (CID 93131858), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).